GlassScriptPhysician profile
Rocco Terrigno
NPI 1477975720
$553.14
in general payments reported to CMS, 2019-2025
12 companies · $40.58 in 2025
The $40.58 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $110 · 2022: $14.39 · 2024: $125 · 2025: $40.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $125.13 | 2024 | Indigo System |
| Portola Pharmaceuticals, LLC | $110.19 | 2020 | |
| Philips North America LLC | $79.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $55.27 | 2019 | |
| Glaxosmithkline, LLC. | $42.77 | 2019 | |
| Ceribell, INC. | $40.58 | 2025 | Pocket Eeg Device |
| Pfizer INC. | $28.63 | 2019 | |
| Mylan Specialty L.P. | $14.76 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.66 | 2019 | |
| Nxstage Medical, INC. | $14.39 | 2022 | |
| Genentech USA, INC. | $13.99 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rocco Terrigno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.